Fort Lauderdale, Fla. — A new technique that delivers protein drugs via disposable contact lenses may eliminate the inefficiency and side effects of eye drops, according to the abstract of a poster presentation at the 2010 Annual Meeting of the Association for Research in Vision and Ophthalmology this week.
Researchers from the University of Western Ontario encapsulated water-soluable proteins that aid with wound healing and blood vessel regeneration into porous nanoparticles. The nanoparticles were then incorporated into disposable contact lenses, which then delivered the protein drugs over time.
According to the abstract, “It is expected that the nanoparticles-laden hydrogel lens materials are a new delivery system to deliver protein drugs, e.g. growth factors, to help blood vessel regeneration and potentiate greater angiogenesis.”
Abstract Name: Encapsulation and Releasing of Protein Drugs through Nanostructured Contact Lens
Presentation Start/End Time: Sunday, May 02, 2010, 8:30 AM -10:15 AM
Program No. 439
Location: Hall D, Broward County Convention Center
# # #
The Association for Research in Vision and Ophthalmology (ARVO) is the largest eye and vision research organization in the world. Members include more than 12,500 eye and vision researchers from over 80 countries. ARVO encourages and assists research, training, publication and knowledge-sharing in vision and ophthalmology. For more information, visit www.arvo.org
All abstracts accepted for presentation at the ARVO Annual Meeting represent previously unpublished data and conclusions. This research may be proprietary or may have been submitted for journal publication. Embargo policy: Journalists must seek approval from the presenter(s) before reporting data from paper or poster presentations. Press releases or stories on information presented at the ARVO Annual Meeting may not be released or published until the conclusion of the presentation.